Logo image of VYX

NCR VOYIX CORP (VYX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:VYX - US62886E1082 - Common Stock

10.02 USD
+0.12 (+1.21%)
Last: 11/25/2025, 2:44:02 PM
Fundamental Rating

3

Taking everything into account, VYX scores 3 out of 10 in our fundamental rating. VYX was compared to 280 industry peers in the Software industry. Both the profitability and financial health of VYX have multiple concerns. VYX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

VYX had positive earnings in the past year.
In the past year VYX has reported a negative cash flow from operations.
In multiple years VYX reported negative net income over the last 5 years.
VYX had a positive operating cash flow in 4 of the past 5 years.
VYX Yearly Net Income VS EBIT VS OCF VS FCFVYX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

VYX's Return On Assets of -1.52% is in line compared to the rest of the industry. VYX outperforms 52.50% of its industry peers.
VYX's Return On Equity of -5.43% is in line compared to the rest of the industry. VYX outperforms 52.50% of its industry peers.
The Return On Invested Capital of VYX (3.31%) is better than 70.36% of its industry peers.
Industry RankSector Rank
ROA -1.52%
ROE -5.43%
ROIC 3.31%
ROA(3y)4.26%
ROA(5y)2.43%
ROE(3y)-21.78%
ROE(5y)-13.67%
ROIC(3y)N/A
ROIC(5y)N/A
VYX Yearly ROA, ROE, ROICVYX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

In the last couple of years the Profit Margin of VYX has grown nicely.
VYX's Operating Margin of 4.57% is fine compared to the rest of the industry. VYX outperforms 67.14% of its industry peers.
In the last couple of years the Operating Margin of VYX has declined.
VYX has a worse Gross Margin (22.76%) than 80.00% of its industry peers.
In the last couple of years the Gross Margin of VYX has declined.
Industry RankSector Rank
OM 4.57%
PM (TTM) N/A
GM 22.76%
OM growth 3Y-43.61%
OM growth 5Y-31.2%
PM growth 3Y208.92%
PM growth 5Y38.43%
GM growth 3Y-8.16%
GM growth 5Y-5.91%
VYX Yearly Profit, Operating, Gross MarginsVYX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VYX is destroying value.
Compared to 1 year ago, VYX has less shares outstanding
Compared to 5 years ago, VYX has more shares outstanding
The debt/assets ratio for VYX has been reduced compared to a year ago.
VYX Yearly Shares OutstandingVYX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
VYX Yearly Total Debt VS Total AssetsVYX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

VYX has an Altman-Z score of 1.26. This is a bad value and indicates that VYX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.26, VYX is in line with its industry, outperforming 41.07% of the companies in the same industry.
VYX has a Debt/Equity ratio of 0.98. This is a neutral value indicating VYX is somewhat dependend on debt financing.
VYX has a worse Debt to Equity ratio (0.98) than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Altman-Z 1.26
ROIC/WACC0.32
WACC10.21%
VYX Yearly LT Debt VS Equity VS FCFVYX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

VYX has a Current Ratio of 1.13. This is a normal value and indicates that VYX is financially healthy and should not expect problems in meeting its short term obligations.
VYX has a Current ratio of 1.13. This is in the lower half of the industry: VYX underperforms 68.21% of its industry peers.
VYX has a Quick Ratio of 1.13. This is a bad value and indicates that VYX is not financially healthy enough and could expect problems in meeting its short term obligations.
VYX's Quick ratio of 0.94 is on the low side compared to the rest of the industry. VYX is outperformed by 76.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.94
VYX Yearly Current Assets VS Current LiabilitesVYX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

VYX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 235.00%, which is quite impressive.
VYX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -31.03% yearly.
The Revenue for VYX has decreased by -61.25% in the past year. This is quite bad
The Revenue for VYX have been decreasing by -16.39% on average. This is quite bad
EPS 1Y (TTM)235%
EPS 3Y-44.54%
EPS 5Y-31.03%
EPS Q2Q%-101.95%
Revenue 1Y (TTM)-61.25%
Revenue growth 3Y-26.63%
Revenue growth 5Y-16.39%
Sales Q2Q%-3.8%

3.2 Future

Based on estimates for the next years, VYX will show a very strong growth in Earnings Per Share. The EPS will grow by 26.41% on average per year.
The Revenue is expected to decrease by -9.48% on average over the next years.
EPS Next Y81.34%
EPS Next 2Y48.89%
EPS Next 3Y26.41%
EPS Next 5YN/A
Revenue Next Year-8.34%
Revenue Next 2Y-12.94%
Revenue Next 3Y-9.48%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VYX Yearly Revenue VS EstimatesVYX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
VYX Yearly EPS VS EstimatesVYX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.37, which indicates a correct valuation of VYX.
VYX's Price/Earnings ratio is rather cheap when compared to the industry. VYX is cheaper than 83.93% of the companies in the same industry.
VYX is valuated cheaply when we compare the Price/Earnings ratio to 25.65, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 10.27 indicates a reasonable valuation of VYX.
Based on the Price/Forward Earnings ratio, VYX is valued cheaply inside the industry as 88.93% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.45, VYX is valued rather cheaply.
Industry RankSector Rank
PE 12.37
Fwd PE 10.27
VYX Price Earnings VS Forward Price EarningsVYX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, VYX is valued cheaply inside the industry as 92.86% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.17
VYX Per share dataVYX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

VYX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as VYX's earnings are expected to grow with 26.41% in the coming years.
PEG (NY)0.15
PEG (5Y)N/A
EPS Next 2Y48.89%
EPS Next 3Y26.41%

0

5. Dividend

5.1 Amount

No dividends for VYX!.
Industry RankSector Rank
Dividend Yield N/A

NCR VOYIX CORP

NYSE:VYX (11/25/2025, 2:44:02 PM)

10.02

+0.12 (+1.21%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners111.5%
Inst Owner ChangeN/A
Ins Owners0.42%
Ins Owner Change8.75%
Market Cap1.39B
Revenue(TTM)2.65B
Net Income(TTM)-61.00M
Analysts85
Price Target16.32 (62.87%)
Short Float %16.24%
Short Ratio17.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP-22.95%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)41.58%
Min EPS beat(2)38.46%
Max EPS beat(2)44.71%
EPS beat(4)4
Avg EPS beat(4)94.55%
Min EPS beat(4)38.46%
Max EPS beat(4)239.46%
EPS beat(8)6
Avg EPS beat(8)41.31%
EPS beat(12)8
Avg EPS beat(12)31.35%
EPS beat(16)11
Avg EPS beat(16)21.93%
Revenue beat(2)2
Avg Revenue beat(2)1.38%
Min Revenue beat(2)1.11%
Max Revenue beat(2)1.66%
Revenue beat(4)3
Avg Revenue beat(4)0.51%
Min Revenue beat(4)-1.67%
Max Revenue beat(4)1.66%
Revenue beat(8)4
Avg Revenue beat(8)-2.13%
Revenue beat(12)6
Avg Revenue beat(12)7.55%
Revenue beat(16)7
Avg Revenue beat(16)5.03%
PT rev (1m)0.79%
PT rev (3m)0.79%
EPS NQ rev (1m)2.58%
EPS NQ rev (3m)0.51%
EPS NY rev (1m)0%
EPS NY rev (3m)1.1%
Revenue NQ rev (1m)2.92%
Revenue NQ rev (3m)3.25%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.15%
Valuation
Industry RankSector Rank
PE 12.37
Fwd PE 10.27
P/S 0.52
P/FCF N/A
P/OCF N/A
P/B 1.23
P/tB N/A
EV/EBITDA 6.17
EPS(TTM)0.81
EY8.08%
EPS(NY)0.98
Fwd EY9.73%
FCF(TTM)-4.35
FCFYN/A
OCF(TTM)-3.18
OCFYN/A
SpS19.16
BVpS8.13
TBVpS-3.52
PEG (NY)0.15
PEG (5Y)N/A
Graham Number12.17
Profitability
Industry RankSector Rank
ROA -1.52%
ROE -5.43%
ROCE 4.19%
ROIC 3.31%
ROICexc 3.67%
ROICexgc 9.58%
OM 4.57%
PM (TTM) N/A
GM 22.76%
FCFM N/A
ROA(3y)4.26%
ROA(5y)2.43%
ROE(3y)-21.78%
ROE(5y)-13.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-36.27%
ROICexgc growth 5Y-25.75%
ROICexc growth 3Y-36.4%
ROICexc growth 5Y-30.51%
OM growth 3Y-43.61%
OM growth 5Y-31.2%
PM growth 3Y208.92%
PM growth 5Y38.43%
GM growth 3Y-8.16%
GM growth 5Y-5.91%
F-Score1
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Debt/EBITDA 3.1
Cap/Depr 69.1%
Cap/Sales 6.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 0.94
Altman-Z 1.26
F-Score1
WACC10.21%
ROIC/WACC0.32
Cap/Depr(3y)67.44%
Cap/Depr(5y)68.37%
Cap/Sales(3y)8.12%
Cap/Sales(5y)6.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)235%
EPS 3Y-44.54%
EPS 5Y-31.03%
EPS Q2Q%-101.95%
EPS Next Y81.34%
EPS Next 2Y48.89%
EPS Next 3Y26.41%
EPS Next 5YN/A
Revenue 1Y (TTM)-61.25%
Revenue growth 3Y-26.63%
Revenue growth 5Y-16.39%
Sales Q2Q%-3.8%
Revenue Next Year-8.34%
Revenue Next 2Y-12.94%
Revenue Next 3Y-9.48%
Revenue Next 5YN/A
EBIT growth 1Y-27.11%
EBIT growth 3Y-58.63%
EBIT growth 5Y-42.48%
EBIT Next Year377.66%
EBIT Next 3Y76.61%
EBIT Next 5Y46.94%
FCF growth 1Y-216.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-148.35%
OCF growth 3YN/A
OCF growth 5YN/A

NCR VOYIX CORP / VYX FAQ

Can you provide the ChartMill fundamental rating for NCR VOYIX CORP?

ChartMill assigns a fundamental rating of 3 / 10 to VYX.


Can you provide the valuation status for NCR VOYIX CORP?

ChartMill assigns a valuation rating of 6 / 10 to NCR VOYIX CORP (VYX). This can be considered as Fairly Valued.


Can you provide the profitability details for NCR VOYIX CORP?

NCR VOYIX CORP (VYX) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for VYX stock?

The Earnings per Share (EPS) of NCR VOYIX CORP (VYX) is expected to grow by 81.34% in the next year.


Can you provide the dividend sustainability for VYX stock?

The dividend rating of NCR VOYIX CORP (VYX) is 0 / 10 and the dividend payout ratio is -22.95%.